Dr. Ron Wald
Claim this profileSt. Michael's Hospital
Studies Kidney Failure
Studies Acute Kidney Injury
8 reported clinical trials
16 drugs studied
Affiliated Hospitals
Clinical Trials Ron Wald is currently running
Dialysis
for Acute Kidney Failure
An estimated 10-15% of critically ill patients with acute kidney failure in the intensive care unit receive acute dialysis therapy. The majority of these patients initially receive a continuous form of dialysis therapy call continuous renal replacement therapy (CRRT). Prior studies have suggested that higher CRRT dose-intensity improved health outcomes for these patients; however, this was not found in high-quality clinical trials. These more recent trials suggested a lower range of dose-intensity compared with the higher range as the new standard of care. This was incorporated into guidelines. To date, no clinical trials have evaluated this lower range and specifically, it is plausible that an even lower dose-intensity of CRRT may be well tolerated, safe, associated with similar outcomes and be more cost-effective. This is the objective of the WISDOM trial, to compare the guideline standard with lower dose-intensity among patients who are started on CRRT in the intensive care unit.
Recruiting1 award N/A3 criteria
Phosphate Level Management
for Kidney Failure
During end-stage kidney disease, clinical guidelines suggest reducing elevated phosphate levels in the blood. However, the effect of lowering blood phosphate levels on important patient-centred outcomes has never been tested. This trial will evaluate whether compared to high levels, lowering blood phosphate levels would reduce death or major events due to heart disease, improve physical health, and be cost-effective.
Recruiting1 award N/A4 criteria
More about Ron Wald
Clinical Trial Related1 year of experience running clinical trials · Led 8 trials as a Principal Investigator · 4 Active Clinical TrialsTreatments Ron Wald has experience with
- Continuous Renal Replacement Therapy (CRRT)
- Intensive Phosphate Target
- Liberal Phosphate Target
- Catheter
- Fistula
- Spironolactone
Breakdown of trials Ron Wald has run
Kidney Failure
Acute Kidney Injury
Dialysis Complications
Chronic Renal Failure
Other Doctors you might be interested in
Frequently asked questions
Do I need insurance to participate in a trial?
Almost all clinical trials will cover the cost of the ‘trial drug’ — so no insurance is required for this. For trials where this trial drug is given alongside an already-approved medication, there may be a cost (which your insurance would normally cover).
What does Ron Wald specialize in?
Ron Wald focuses on Kidney Failure and Acute Kidney Injury. In particular, much of their work with Kidney Failure has involved treating patients, or patients who are undergoing treatment.
Is Ron Wald currently recruiting for clinical trials?
Yes, Ron Wald is currently recruiting for 4 clinical trials in Toronto Ontario. If you're interested in participating, you should apply.
Are there any treatments that Ron Wald has studied deeply?
Yes, Ron Wald has studied treatments such as Continuous Renal Replacement Therapy (CRRT), Intensive phosphate target, Liberal phosphate target.
What is the best way to schedule an appointment with Ron Wald?
Apply for one of the trials that Ron Wald is conducting.
What is the office address of Ron Wald?
The office of Ron Wald is located at: St. Michael's Hospital, Toronto, Ontario M5B 1W8 Canada. This is the address for their practice at the St. Michael's Hospital.
Is there any support for travel costs?
The coverage of travel expenses can vary greatly between different clinical trials. Please see more financial detail in the trials you’re interested to apply.
Unbiased ResultsWe believe in providing patients with all the options.
Your Data Stays Your DataWe only share your information with the clinical trials you're trying to access.
Verified Trials OnlyAll of our trials are run by licensed doctors, researchers, and healthcare companies.